REX vs TMO · P/E 15, rev $642.5M vs P/E 24, rev $44.56B
REX American Resources Corporation (REX) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
REX currently screens at market cap $1.43B and trailing P/E 15.5. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the REX and TMO stock pages for the full models.
Not investment advice.